Vishangi Dave
Experienced in Iron Deficiency Anemia

Dr. Vishangi Dave

Otolaryngology | Oncology | Hematology
Banner Health
Banner MD Anderson Cancer Center Medical Oncology Clinic
13041 North Del Webb Boulevard, Suite 200, 
Sun City, AZ 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in Iron Deficiency Anemia
Banner Health
Banner MD Anderson Cancer Center Medical Oncology Clinic
13041 North Del Webb Boulevard, Suite 200, 
Sun City, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I enjoy spending time with family and friends, hiking, gardening.

Dr. Dave is rated as an Experienced provider by MediFind in the treatment of Iron Deficiency Anemia. Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Familial Prostate Cancer.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Pramukhswami Medical College, 2010
Residency
South Brooklyn Health, Internal Medicine, 2015
Specialties
Otolaryngology
Oncology
Hematology
Licenses
Internal Medicine in AZ
Board Certifications
American Board Of Internal Medicine/Medical Oncology
American Board Of Internal Medicine
American Board Of Internal Medicine/Hematology
Fellowships
Maimonides Medical Center, Hematology/Oncology, 2018
Hospital Affiliations
Banner Boswell Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Banner MD Anderson Cancer Center Medical Oncology Clinic
13041 North Del Webb Boulevard, Suite 200, Sun City, AZ 85351

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
Enrollment Status: Recruiting
Publish Date: December 11, 2025
Intervention Type: Procedure, Drug, Biological, Other
Study Drugs: Gemcitabine, Cisplatin, Pegfilgrastim
Study Phase: Phase 2
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
Enrollment Status: Suspended
Publish Date: December 17, 2025
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 3
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Drug, Biological, Procedure, Other, Radiation
Study Drugs: Brentuximab, Dacarbazine, Doxorubicin, Filgrastim, Nivolumab, Pegfilgrastim, Vinblastine
Study Phase: Phase 3
A Randomized Phase 2 Trial of Axitinib/Nivolumab Combination Therapy vs. Single Agent Nivolumab for the Treatment of TFE/Translocation Renal Cell Carcinoma (tRCC) Across All Age Groups
A Randomized Phase 2 Trial of Axitinib/Nivolumab Combination Therapy vs. Single Agent Nivolumab for the Treatment of TFE/Translocation Renal Cell Carcinoma (tRCC) Across All Age Groups
Enrollment Status: Active_not_recruiting
Publish Date: December 03, 2025
Intervention Type: Drug, Biological
Study Drugs: Axitinib, Nivolumab
Study Phase: Phase 2
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2025
Intervention Type: Drug, Other, Biological
Study Drugs: Dasatinib, Imatinib Mesylate, Nilotinib, Pembrolizumab
Study Phase: Phase 2
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

3 Total Publications

Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer.
Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer.
Journal: World journal of clinical oncology
Published: January 03, 2019
View All 3 Publications
Similar Doctors
Distinguished in Iron Deficiency Anemia
Dr. Justin M. Goldfarb
Oncology | Hematology Oncology
Distinguished in Iron Deficiency Anemia
Dr. Justin M. Goldfarb
Oncology | Hematology Oncology

Honorhealth Ambulatory

10320 W Mcdowell Rd, Suite 9030, 
Avondale, AZ 
 (9.5 miles away)
480-359-7384
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Justin Goldfarb is an Oncologist and a Hematologist Oncology provider in Avondale, Arizona. Dr. Goldfarb is rated as a Distinguished provider by MediFind in the treatment of Iron Deficiency Anemia. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma. Dr. Goldfarb is currently accepting new patients.

Advanced in Iron Deficiency Anemia
Dr. John L. Bibb
Oncology | Hematology Oncology | Hematology
Advanced in Iron Deficiency Anemia
Dr. John L. Bibb
Oncology | Hematology Oncology | Hematology

Honorhealth Ambulatory

9250 N 3rd St, Suite 3010, 
Phoenix, AZ 
 (12.5 miles away)
855-485-4673
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

John Bibb is an Oncologist and a Hematologist Oncology provider in Phoenix, Arizona. Dr. Bibb is rated as a Distinguished provider by MediFind in the treatment of Iron Deficiency Anemia. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Hemochromatosis, and Pleuropulmonary Blastoma. Dr. Bibb is currently accepting new patients.

Advanced in Iron Deficiency Anemia
Dr. Rajinder Grover
Oncology | Hematology Oncology | Hematology
Advanced in Iron Deficiency Anemia
Dr. Rajinder Grover
Oncology | Hematology Oncology | Hematology

Palo Verde Hematology Oncology Ltd

7373 N Scottsdale Rd, E100, 
Scottsdale, AZ 
 (21.1 miles away)
602-978-6255
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rajinder Grover is an Oncologist and a Hematologist Oncology provider in Scottsdale, Arizona. Dr. Grover is rated as a Distinguished provider by MediFind in the treatment of Iron Deficiency Anemia. His top areas of expertise are Deep Vein Thrombosis, Pulmonary Embolism, Thrombocytopenia, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration.

VIEW MORE IRON DEFICIENCY ANEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dave's expertise for a condition
ConditionClose
      • Advanced
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Dave is
        Advanced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Chronic B-Cell Leukemia (CBCL)
        Dr. Dave is
        Advanced
        . Learn about Chronic B-Cell Leukemia (CBCL).
        See more Chronic B-Cell Leukemia (CBCL) experts
      • Chronic Lymphocytic Leukemia (CLL)
        Dr. Dave is
        Advanced
        . Learn about Chronic Lymphocytic Leukemia (CLL).
        See more Chronic Lymphocytic Leukemia (CLL) experts
      • EGFR Positive Lung Cancer
        Dr. Dave is
        Advanced
        . Learn about EGFR Positive Lung Cancer.
        See more EGFR Positive Lung Cancer experts
      • Familial Prostate Cancer
        Dr. Dave is
        Advanced
        . Learn about Familial Prostate Cancer.
        See more Familial Prostate Cancer experts
      • Large-Cell Lung Carcinoma
        Dr. Dave is
        Advanced
        . Learn about Large-Cell Lung Carcinoma.
        See more Large-Cell Lung Carcinoma experts
      View All 14 Advanced Conditions
      • Experienced
      • Acute Mountain Sickness
        Dr. Dave is
        Experienced
        . Learn about Acute Mountain Sickness.
        See more Acute Mountain Sickness experts
      • Adult Immune Thrombocytopenia
        Dr. Dave is
        Experienced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • Adult Soft Tissue Sarcoma
        Dr. Dave is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Alveolar Soft Part Sarcoma
        Dr. Dave is
        Experienced
        . Learn about Alveolar Soft Part Sarcoma.
        See more Alveolar Soft Part Sarcoma experts
      • Anemia
        Dr. Dave is
        Experienced
        . Learn about Anemia.
        See more Anemia experts
      • Angiosarcoma
        Dr. Dave is
        Experienced
        . Learn about Angiosarcoma.
        See more Angiosarcoma experts
      View All 80 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.